A regional analysis of epidermal growth factor receptor ( EGFR ) mutated lung cancer for HSE South

Deirdre Kelly,L. Mc Sorley,E O Shea,E. Mc Carthy,S. Bowe,Claire Brady,Jane Sze Yin Sui,Mohammed Adam Ibrahim Dawod,O. OBrien,D. Graham,Julie McCarthy,Liam Burke,Derek G. Power,Seamus O’Reilly,Richard Martin Bambury,D. O’Mahony

A regional analysis of epidermal growth factor receptor ( EGFR ) mutated lung cancer for HSE South

2017

Deirdre Kelly
L. Mc Sorley
E O Shea
E. Mc Carthy
S. Bowe
Claire Brady
Jane Sze Yin Sui
Mohammed Adam Ibrahim Dawod
O. OBrien
D. Graham
Julie McCarthy
Liam Burke
Derek G. Power
Seamus O’Reilly
Richard Martin Bambury
D. O’Mahony

Background EGFR mutated lung cancer represents a subgroup with distinct clinical presentations, prognosis, and management requirements. We investigated the survival, prognostic factors, and real-world treatment of NSCLC patients with EGFR mutation in clinical practice.

Keywords:

Surgery
Clinical Practice
Epidermal growth factor receptor
Cancer research
Lung cancer
Pathology
Medicine
Diabetes mellitus
Oncology
egfr mutation
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations